What does Apotheek Verfaillie do?

Apotheek Verfaillie is a pharmacy in Tielt. Public Limited, started on 25 May 1991, 1 establishment.

What is the address of Apotheek Verfaillie?

The registered office of Apotheek Verfaillie is located at Ieperstraat 3-5, 8700 Tielt.

Is Apotheek Verfaillie still active?

Yes. According to the CBE (30 October 2026) Apotheek Verfaillie is active, legal situation “Normale toestand”, started on 25 May 1991.

Is Apotheek Verfaillie registered on Peppol?

Yes, Apotheek Verfaillie is registered on the Peppol network with ID 0208:0444210609.

What is the enterprise number of Apotheek Verfaillie?

The enterprise number of Apotheek Verfaillie is BE0444210609.

When was Apotheek Verfaillie founded?

Apotheek Verfaillie was founded on 25 May 1991.

Who are the directors of Apotheek Verfaillie?

According to the 2025 annual accounts, the directors of Apotheek Verfaillie are: VERBIFARMA BV.

Is Apotheek Verfaillie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 May 1991; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek Verfaillie make in 2025?

Apotheek Verfaillie recorded a loss after taxes of € 55,936 in financial year 2025.

What is the revenue of Apotheek Verfaillie?

As a small company, Apotheek Verfaillie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 147,126.

How much does an employee at Apotheek Verfaillie earn?

The average wage cost per full-time employee at Apotheek Verfaillie was € 52,800 in 2025: staff costs of € 84,556 for 1.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Verfaillie have?

According to the 2025 annual accounts, Apotheek Verfaillie has 1.6 full-time equivalents (FTE).

Apotheek Verfaillie (Public Limited) - Tielt

Dossier Apotheek Verfaillie, printed on 30 October 2026 from databakkes.be/en/0444210609/apotheek-verfaillie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek Verfaillie from Tielt, company number BE0444210609, closed financial year 2025 with a result of € -55,936 after tax. For that financial year Apotheek Verfaillie recorded a gross margin of € 147,126 and equity of € 386,174. Compared with financial year 2024, the result moved from € 34,463 to € -55,936. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 13, 2026.

What it is worth Healthy

€ 386,174

▼ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -55,936

▼ still € 34,463 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 78,040

▲ 82% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 137,193.

People and assets in 2025

Full-time equivalents

1.6

▲ 0.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 84,556

▲ 64% vs 2024

€ 52,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 28,712

▼ 19% vs 2024

Of which on lease € 25,366.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 26,051

▼ 89% vs 2024

€ 10,484 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 123,258

▲ € 94,249 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 8,927

▲ 16% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 78,957 Gross margin 2022: € 78,957 First fiscal year in the series	€ 138,352 Gross margin 2023: € 138,352 ▲ 75% vs 2022 (€ 78,957) Favourable step	€ 127,303 Gross margin 2024: € 127,303 ▼ 8% vs 2023 (€ 138,352) Unfavourable step	€ 147,126 Gross margin 2025: € 147,126 ▲ 16% vs 2024 (€ 127,303) Favourable step	▲ 16%
Profit after taxes	€ 4,395 Profit after taxes 2022: € 4,395 First fiscal year in the series	€ -58,314 Profit after taxes 2023: € -58,314 ▼ € 62,709 vs 2022 (€ 4,395) Unfavourable step	€ 34,463 Profit after taxes 2024: € 34,463 ▲ € 92,777 vs 2023 (€ -58,314) Favourable step	€ -55,936 Profit after taxes 2025: € -55,936 ▼ € 90,399 vs 2024 (€ 34,463) Unfavourable step	▼ € 90,399
Equity	€ 465,961 Equity 2022: € 465,961 First fiscal year in the series	€ 407,647 Equity 2023: € 407,647 ▼ 13% vs 2022 (€ 465,961) Unfavourable step	€ 442,110 Equity 2024: € 442,110 ▲ 8% vs 2023 (€ 407,647) Favourable step	€ 386,174 Equity 2025: € 386,174 ▼ 13% vs 2024 (€ 442,110) Unfavourable step	▼ 13%
Total debts	€ 387,919 Total debts 2022: € 387,919 First fiscal year in the series	€ 388,657 Total debts 2023: € 388,657 Unchanged (€ 387,919) Unfavourable step	€ 269,756 Total debts 2024: € 269,756 ▼ 31% vs 2023 (€ 388,657) Favourable step	€ 160,773 Total debts 2025: € 160,773 ▼ 40% vs 2024 (€ 269,756) Favourable step	▼ 40%
Cash	€ 68,673 Cash 2022: € 68,673 First fiscal year in the series	€ 21,013 Cash 2023: € 21,013 ▼ 69% vs 2022 (€ 68,673) Unfavourable step	€ 42,873 Cash 2024: € 42,873 ▲ 104% vs 2023 (€ 21,013) Favourable step	€ 78,040 Cash 2025: € 78,040 ▲ 82% vs 2024 (€ 42,873) Favourable step	▲ 82%
Land & buildings	€ 412,173 Land & buildings 2022: € 412,173 First fiscal year in the series	€ 390,205 Land & buildings 2023: € 390,205 ▼ 5% vs 2022 (€ 412,173) Unchanged	€ 388,901 Land & buildings 2024: € 388,901 Unchanged (€ 390,205) Unchanged	€ 0 Land & buildings 2025: € 0 ▼ 100% vs 2024 (€ 388,901) Unchanged	▼ 100%
Retained profit	€ 216,979 Retained profit 2022: € 216,979 First fiscal year in the series	€ 158,666 Retained profit 2023: € 158,666 ▼ 27% vs 2022 (€ 216,979) Unfavourable step	€ 193,129 Retained profit 2024: € 193,129 ▲ 22% vs 2023 (€ 158,666) Favourable step	€ 137,193 Retained profit 2025: € 137,193 ▼ 29% vs 2024 (€ 193,129) Unfavourable step	▼ 29%
Bank debt	€ 290,417 Bank debt 2022: € 290,417 First fiscal year in the series	€ 262,282 Bank debt 2023: € 262,282 ▼ 10% vs 2022 (€ 290,417) Favourable step	€ 230,367 Bank debt 2024: € 230,367 ▼ 12% vs 2023 (€ 262,282) Favourable step	€ 26,051 Bank debt 2025: € 26,051 ▼ 89% vs 2024 (€ 230,367) Favourable step	▼ 89%
Balance sheet total	€ 853,879 Balance sheet total 2022: € 853,879 First fiscal year in the series	€ 796,304 Balance sheet total 2023: € 796,304 ▼ 7% vs 2022 (€ 853,879) Unchanged	€ 711,866 Balance sheet total 2024: € 711,866 ▼ 11% vs 2023 (€ 796,304) Unchanged	€ 546,947 Balance sheet total 2025: € 546,947 ▼ 23% vs 2024 (€ 711,866) Unchanged	▼ 23%
Employees (FTE)	1.3 Employees (FTE) 2022: 1.3 First fiscal year in the series	1 Employees (FTE) 2023: 1 ▼ 0.3 vs 2022 (1.3) Unchanged	0.8 Employees (FTE) 2024: 0.8 ▼ 0.2 vs 2023 (1) Unchanged	1.6 Employees (FTE) 2025: 1.6 ▲ 0.8 vs 2024 (0.8) Unchanged	▲ 0.8

Key figures of Apotheek Verfaillie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Verfaillie?

What happened at Apotheek Verfaillie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 13, 2026 New annual accounts for financial year 2025: loss of € 55,936 (▼ € 90,399 vs 2024). Source: NBB ↗
Jun 17, 1991 New establishment in Tielt. KBO
May 25, 1991 Start of the company according to the CBE. KBO

In short

From € 4,395 profit in 2022 to € 55,936 loss in 2025.

Paid € 689 in corporate taxes since 2022.

Best year ever: 2024, with € 34,463 profit.

On average € 92,000 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

VERBIFARMA 100%

The stake of VERBIFARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Verfaillie

Behind Apotheek Verfaillie is VERBIFARMA BV. The shares are held by VERBIFARMA (100%).

Directors

According to the 2025 annual accounts

VERBIFARMA BV

Director · represented by Verfaillie Bieke

Shareholders

VERBIFARMA

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Ieperstraat 3-5

8700 Tielt

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0444.210.609

VAT number

BE 0444.210.609

Registered office

Ieperstraat 3-5, 8700 Tielt

Names & denominations

Apotheek Verfaillie · BAUW

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

25 May 1991

Peppol

Active · Active since 18 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Activiteiten van bouwarchitecten

Architecten

View on CBE Public ↗ Annual accounts (NBB) ↗